Nashville Biosciences
Coleman Harris has a diverse work experience in the field of data science and analytics. Coleman started their career as a Research Assistant at the University of Alabama MINT Center in 2015. Coleman then worked as a Sales Associate at Sun & Ski from 2015 to 2017. In 2017, they were an Intern at Aegis Sciences Corporation.
Coleman pursued higher education as a PhD Candidate at Vanderbilt University School of Medicine from 2017 to 2022. During this time, they also worked as a Data Science Intern at Nashville Biosciences from 2020 to 2020 and as a Content Writer at Nebula Genomics from 2019 to 2020.
In 2020, Coleman joined Decode Health as a Data Analyst, where they worked until 2022. Coleman also served as a Data Science Intern at Nashville Biosciences during this period. In 2021, they worked as a Content Writer at Kaizen Analytix and as a Technical Writer at Keshif from 2020 to 2021.
Currently, Coleman is working as a Data Engineer at Nashville Biosciences, starting in 2022.
Coleman Harris earned a Bachelor of Science (B.S.), cum laude, in Mathematics and Statistics from The University of Alabama between 2015 and 2017. From 2017 to 2022, they pursued a Doctor of Philosophy (PhD) degree in Biostatistics at Vanderbilt University.
This person is not in any teams
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.